Pleuropulmonalni blastom - prikaz slučaja

Autor(i)

  • Maja Pavlović Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska
  • Iva Tkalčec Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska
  • Jelena Roganović Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska

DOI:

https://doi.org/10.13112/pc.1122

Ključne riječi:

pleuropulmonalni blastom; neoplazme pluća; djeca

Sažetak

Cilj: Cilj rada je prikazati izazove u postavljanju dijagnoze i liječenju pleuropulmonalnog blastoma.

Prikaz slučaja: Petomjesečno muško dojenče hospitalizirano je zbog desnostranog pneumotoraksa u sklopu bronhiolitisa uzrokovanog respiratornim sincicijskim virusom. Slikovna obrada prikazala je bulu u desnom plućnom krilu. Nakon resekcije, patohistološkom analizom postavljena je dijagnoza kongenitalne cistične adenomatoidne malformacije pluća tipa I. U dobi od 2.5 godine, tijekom liječenja pleuropneumonije, kod pacijenta je otkrivena solidno-cistična tumorska tvorba desnog hemitoraksa. Ultrazvučno vođenom iglenom biopsijom postavljena je dijagnoza sarkoma iz obitelji Ewing. Nakon neoadjuvantne kemoterapije učinjena je desnostrana bilobektomija. Patohistološka analiza potvrdila je pleuropulmonalni blastom tipa II, a genomsko sekvenciranje patogenu varijantu DICER1 gena. Ista mutacija dokazana je i u zametnoj liniji, čime je potvrđen DICER1 sindrom. Sedam mjeseci nakon završetka terapije pacijent je bez znakova bolesti te urednog tjelesnog i psihomotornog razvoja.

Zaključak: Pleuropulmonalni blastom rijedak je i agresivan intratorakalni tumor koji treba razmotriti u diferencijalnoj dijagnozi kongenitalnih malformacija pluća, plućnih ili bronhalnih cisti te pneumotoraksa. Pravodobno prepoznavanje i multidisciplinarno liječenje, koje uključuje kirurški zahvat i kemoterapiju, ključni su za povoljnu prognozu bolesti.

Biografije autora

  • Maja Pavlović, Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska

    dr.med., specijalist pedijatar, subspecijalist pedijatrijske hematologije i onkologije

  • Iva Tkalčec, Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska

    dr.med.

  • Jelena Roganović, Klinika za dječje bolesti Zagreb, Klaićeva 16, Zagreb, Hrvatska

    dr.med., specijalist pedijatar, subspecijalist pedijatrijske hematologije i onkologije, primarijus, redoviti profesor u trajnom zvanju

Reference

1. Smith NJ, Mukherjee D, Wang Y, Brazauskas R, Nelson AA, Cortina CS. Epidemiology and outcomes of primary pediatric lung malignancies: updates from the SEER database. Am J Surg 2021;222:861-866. doi:10.1016/j.amjsurg.2021.01.037

2. Bisogno G, Carli M, Casanova M, Cecchetto G, Godzinski J, Grosfeld J, et al. Pleuropulmonary blastoma in children and adolescents: the EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer 2021;68:e29045. doi:10.1002/pbc.29045

3. Manivel JC, Priest JR, Watterson J, Steiner M, Woods WG, Wick MR, et al. Pleuropulmonary blastoma: the so-called pulmonary blastoma of childhood. Cancer 1988;62:1516-1526.

4. Mlika M, Anjum F, El Mezni F. Pleuropulmonary blastoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [accessed 2025 Aug 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534211/

5. Priest JR, Williams GM, Hill DA, Dehner LP, Jaffé A, Hill JG, et al. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol 2006;24:4492-4498. doi:10.1200/JCO.2005.05.3595

6. Zhang N, Liu L, Wang L, Bao N, Qiu G, Chen S, et al. Diagnosis and treatment of pleuropulmonary blastoma in children: a single-center report of 41 cases. J Pediatr Surg 2020;55:1351-1355. doi:10.1016/j.jpedsurg.2019.06.009

7. Lezmi G, Verkarre V, Khen-Dunlop N, Vibhushan S, Hadchouel A, Rambaud C, et al. FGF10 signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation. Orphanet J Rare Dis 2013;8:130. doi:10.1186/1750-1172-8-130

8. Oliveira C, Himidan S, Pastor A, Nasr A, Manson D, Taylor G, et al. Discriminating preoperative features of pleuropulmonary blastomas (PPB) from congenital cystic adenomatoid malformations (CCAM): a retrospective, age-matched study. Eur J Pediatr Surg 2011;21:2-7. doi:10.1055/s-0030-1267923

9. Faure A, Bouty A, Carfagna L, Alessandrini P, Bachy B, Blanc T, et al. DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: what the paediatric urologist needs to know. J Pediatr Urol 2016;12:5-10. doi:10.1016/j.jpurol.2015.08.012

10. Schultz KAP. DICER1 tumor predisposition. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2020 [accessed 2025 Aug 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK196157/

11. Bisogno G, Brennan B, Orbach D, Stoneham S, Fossati-Bellani F, Laureys G, et al. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer 2014;50:178-184. doi:10.1016/j.ejca.2013.08.015

12. Caroleo AM, Colafiglio T, Medagli B, Volante M, De Leonardis F, Secinaro A, et al. DICER1 syndrome and cancer predisposition: from a rare pediatric tumor to lifetime risk. Front Oncol 2021;10:614541. doi:10.3389/fonc.2020.614541

13. González IA, Jongmans MC, van der Luijt RB, Boshari T, Kets CM, Campos A, et al. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol 2022;35:4-22. doi:10.1038/s41379-021-00905-8

14. Heidemann SM, Sapru A, Jacobs B, Shanley TP, Meert K, Berg RA, et al. Pathophysiology and management of acute respiratory distress syndrome in children. Pediatr Clin North Am 2017;64:1017-1037. doi:10.1016/j.pcl.2017.06.004

15. das Posses Bridi G, Santoro IL, Constantino LV, Fumis RRL, Forte GC, et al. Drug-induced lung disease: a narrative review. J Bras Pneumol 2024;50:e20240110. doi:10.36416/1806-3756/e20240110

16. Dhokarh R, Li G, Schmickl CN, Kashyap R, Assudani J, Limper AH, et al. Drug-associated acute lung injury. Chest 2012;142:845-850. doi:10.1378/chest.11-2103

17. Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg 2008;17:17-29. doi:10.1053/j.sempedsurg.2007.10.004

18. UK Clinical Genetics Group. UKCGG consensus guideline for the clinical management of individuals with germline DICER1 pathogenic variants. UK Clinical Genetics Group website. 2024 Jan 26 [accessed 2025 Aug 10]. Available from: https://www.ukcgg.org/media/12633/ukcgg_dicer1_guideline_v1_26012024.pdf

19. Bakhuizen JJ, Keskin E, Adank MA, Bozali F, Collins RT, Dehner LP, et al. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group. Fam Cancer 2021;20:337-348. doi:10.1007/s10689-021-00264-y

Preuzimanja

Objavljeno

16.12.2025

Broj časopisa

Rubrika

Prikaz slučaja

Kako citirati

Pavlović, M., Tkalčec, I., & Roganović, J. (2025). Pleuropulmonalni blastom - prikaz slučaja. Paediatria Croatica, 69(4), 244-251. https://doi.org/10.13112/pc.1122

Similar Articles

1-10 od 147

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)